Detalhe da pesquisa
1.
4-Acetylantroquinonol B Suppresses Prostate Cancer Growth and Angiogenesis via a VEGF/PI3K/ERK/mTOR-Dependent Signaling Pathway in Subcutaneous Xenograft and In Vivo Angiogenesis Models.
Int J Mol Sci
; 23(3)2022 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35163369
2.
Trowaglerix Venom Polypeptides As a Novel Antithrombotic Agent by Targeting Immunoglobulin-Like Domains of Glycoprotein VI in Platelet.
Arterioscler Thromb Vasc Biol
; 37(7): 1307-1314, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28596377
3.
Anti-thrombotic agents derived from snake venom proteins.
Thromb J
; 14(Suppl 1): 18, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27766044
4.
Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
Carcinogenesis
; 33(5): 1022-30, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22436611
5.
Atherosclerosis amelioration by allicin in raw garlic through gut microbiota and trimethylamine-N-oxide modulation.
NPJ Biofilms Microbiomes
; 8(1): 4, 2022 01 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35087050
6.
Improved Antithrombotic Activity and Diminished Bleeding Side Effect of a PEGylated αIIbß3 Antagonist, Disintegrin.
Toxins (Basel)
; 12(7)2020 06 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32605221
7.
2'-Ethoxy-5'-methoxy-2-(5-methylthienyl)chalcone inhibits collagen-induced protein tyrosine phosphorylation and thromboxane formation during platelet aggregation and adhesion.
Pharmacology
; 84(3): 145-52, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19690443
8.
FcgammaRII mediates platelet aggregation caused by disintegrins and GPIIb/IIIa monoclonal antibody, AP2.
Exp Hematol
; 36(12): 1704-13, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18809237
9.
From Discovery of Snake Venom Disintegrins to A Safer Therapeutic Antithrombotic Agent.
Toxins (Basel)
; 11(7)2019 06 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-31247995
10.
Extracellular vesicles from CLEC2-activated platelets enhance dengue virus-induced lethality via CLEC5A/TLR2.
Nat Commun
; 10(1): 2402, 2019 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31160588
11.
A Novel αIIbß3 Antagonist from Snake Venom Prevents Thrombosis without Causing Bleeding.
Toxins (Basel)
; 12(1)2019 12 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-31877725
12.
A novel 2-aminobenzimidazole-based compound Jzu 17 exhibits anti-angiogenesis effects by targeting VEGFR-2 signalling.
Br J Pharmacol
; 176(20): 4034-4049, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31368127
13.
Lycopene inhibits TNF-alpha-induced endothelial ICAM-1 expression and monocyte-endothelial adhesion.
Eur J Pharmacol
; 586(1-3): 275-82, 2008 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-18439578
14.
Synthesis of 2,3-disubstituted 1,4-naphthoquinones as antiplatelet agents.
Arch Pharm (Weinheim)
; 341(10): 639-44, 2008 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-18720342
15.
Inhibitory Effects of an Orally Active Thromboxane A2 Receptor Antagonist, nstpbp5185, on Atherosclerosis in ApoE-Deficient Mice.
Thromb Haemost
; 118(2): 401-414, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29378362
16.
A segment of Staphylococcus aureus clumping factor A with fibrinogen-binding activity (ClfA221-550) inhibits platelet-plug formation in mice.
Thromb Res
; 121(2): 183-91, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17467042
17.
Trimucrin, an Arg-Gly-Asp containing disintegrin, attenuates myocardial ischemia-reperfusion injury in murine by inhibiting platelet function.
Eur J Pharmacol
; 813: 24-32, 2017 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28739088
18.
Aggretin Venom Polypeptide as a Novel Anti-angiogenesis Agent by Targeting Integrin alpha2beta1.
Sci Rep
; 7: 43612, 2017 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28252668
19.
Correction to 4-Acetylantroquinonol B Suppresses Tumor Growth and Metastasis of Hepatoma Cells via Blockade of Translation-Dependent Signaling Pathway and VEGF Production.
J Agric Food Chem
; 70(3): 901, 2022 Jan 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35029984
20.
The disintegrin, trimucrin, suppresses LPS-induced activation of phagocytes primarily through blockade of NF-κB and MAPK activation.
Naunyn Schmiedebergs Arch Pharmacol
; 389(7): 723-37, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-27030393